NCT03846193 FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD Status TERMINATED Phase PHASE1/PHASE2
NCT03839823 Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT03834922 Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment Status COMPLETED Phase N/A
NCT03832114 Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted Status COMPLETED Phase PHASE2
NCT03828539 Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine Status COMPLETED Phase PHASE4
NCT03828201 Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03827798 Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03825289 Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT03822468 Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT03814746 Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03814187 Trial to Assess the Effect of Long Term Dosing of Inclisiran in Subjects With High CV Risk and Elevated LDL-C Status COMPLETED Phase PHASE3
NCT03810313 Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion Status TERMINATED Phase PHASE3
NCT03810183 A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia Status TERMINATED Phase PHASE2
NCT03809611 A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. Status COMPLETED Phase PHASE2
NCT03804879 Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy Status COMPLETED Phase PHASE2
NCT03802630 Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion Status TERMINATED Phase PHASE3
NCT03798626 Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers Status COMPLETED Phase PHASE1
NCT03791060 Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD) Status TERMINATED Phase PHASE2
NCT03785405 Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF Status COMPLETED Phase PHASE3
NCT03781414 Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension Status TERMINATED Phase PHASE2